$AGNPF #OTCQB Algernon Pharmaceuticals Inc. (AGNPF: OTCQB) | Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial
Copyright 2021 – OTC Markets Group Inc.

News Link